These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 11153446)
21. Partial pharmacodynamic model for the circadian-episodic secretion of cortisol in man. Jusko WJ; Slaunwhite WR; Aceto T J Clin Endocrinol Metab; 1975 Feb; 40(2):278-89. PubMed ID: 163972 [TBL] [Abstract][Full Text] [Related]
22. Mathematical modeling of circadian cortisol concentrations using indirect response models: comparison of several methods. Chakraborty A; Krzyzanski W; Jusko WJ J Pharmacokinet Biopharm; 1999 Feb; 27(1):23-43. PubMed ID: 10533696 [TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of methylprednisolone acetate after intra-articular administration and subsequent suppression of endogenous hydrocortisone secretion in exercising horses. Menéndez MI; Phelps MA; Hothem EA; Bertone AL Am J Vet Res; 2012 Sep; 73(9):1453-61. PubMed ID: 22924728 [TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of methylprednisolone acetate after intra-articular administration and its effect on endogenous hydrocortisone and cortisone secretion in horses. Soma LR; Uboh CE; Luo Y; Guan F; Moate PJ; Boston RC Am J Vet Res; 2006 Apr; 67(4):654-62. PubMed ID: 16579759 [TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetic and pharmacoimmunodynamic interactions between prednisolone and sirolimus in adrenalectomized rats. Ferron GM; Pyszczynski NA; Jusko WJ J Pharmacokinet Biopharm; 1999 Feb; 27(1):1-21. PubMed ID: 10533695 [TBL] [Abstract][Full Text] [Related]
26. Methylprednisolone exposure, rather than dose, predicts adrenal suppression and growth inhibition in children with liver and renal transplants. Sarna S; Hoppu K; Neuvonen PJ; Laine J; Holmberg C J Clin Endocrinol Metab; 1997 Jan; 82(1):75-7. PubMed ID: 8989236 [TBL] [Abstract][Full Text] [Related]
27. Diltiazem and mibefradil increase the plasma concentrations and greatly enhance the adrenal-suppressant effect of oral methylprednisolone. Varis T; Backman JT; Kivistö KT; Neuvonen PJ Clin Pharmacol Ther; 2000 Mar; 67(3):215-21. PubMed ID: 10741623 [TBL] [Abstract][Full Text] [Related]
28. Dose equivalency evaluation of major corticosteroids: pharmacokinetics and cell trafficking and cortisol dynamics. Mager DE; Lin SX; Blum RA; Lates CD; Jusko WJ J Clin Pharmacol; 2003 Nov; 43(11):1216-27. PubMed ID: 14551176 [TBL] [Abstract][Full Text] [Related]
29. Differential gene expression in B cells and T helper cells following high-dose glucocorticoid therapy for multiple sclerosis relapse. Hecker M; Fitzner B; Koczan D; Klehmet J; Grothe M; Schwab M; Winkelmann A; Meister S; Dudesek A; Ludwig-Portugall I; Eulitz K; Zettl UK Biomed Pharmacother; 2024 Jun; 175():116721. PubMed ID: 38749180 [TBL] [Abstract][Full Text] [Related]
30. Bovine plasma and synovial fluid kinetics of methylprednisolone and methylprednisolone acetate after intra-articular administration of methylprednisolone acetate. Toutain PL; Alvinerie M; Fayolle P; Ruckebusch Y J Pharmacol Exp Ther; 1986 Mar; 236(3):794-802. PubMed ID: 3950871 [TBL] [Abstract][Full Text] [Related]
33. Synovial fluid and plasma kinetics of methylprednisolone and methylprednisolone acetate in horses following intra-articular administration of methylprednisolone acetate. Autefage A; Alvinerie M; Toutain PL Equine Vet J; 1986 May; 18(3):193-8. PubMed ID: 3732238 [TBL] [Abstract][Full Text] [Related]